Breaking News Headlines Today | Ground News

See every side of every news story

Multiple Sclerosis Research Blog image

News from Multiple Sclerosis Research Blog

See all of Multiple Sclerosis Research Blog’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

Overall, we’ve indexed 50 stories from Multiple Sclerosis Research Blog over the past 3 months.

Multiple Sclerosis Research Blog’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Multiple Sclerosis Research Blog’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Multiple Sclerosis Research Blog

Where is Multiple Sclerosis Research Blog located?Multiple Sclerosis Research Blog's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Multiple Sclerosis Research Blog News

Quantum BioPharma Submits Its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in ...

Multiple Sclerosis · United Kingdom

Quantum BioPharma Submits Its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in ...

Coverage: 5 sources

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)See the Story

Neural Stem Cell Grafts Show Promise for Myelin Repair in Multiple Sclerosis

Neural Stem Cell Grafts Show Promise for Myelin Repair in Multiple Sclerosis

Coverage: 2 sources

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system.See the Story

5 years on ofatumumab

London, England · London

5 years on ofatumumab

Tweet Ofataumumab is an anti CD20 antibody injected under the skin. It inhibits relapsing MS and 5 years later is still doing the same. The selling point is that this can be done at home and that it inhibits progressive disability says that the central driver for this is due to stopping B cells getting in the brain. I say this because I am not convinced the antibody gets in the brain the blood levels are about 4 microgramme a millilitre so a tho…Read Article

Measuring Neurofilaments with a Prick

Coleman A, Touzé A, Farag M, Pengo M, Murphy MJ, Hassan Y, Thackeray O, Fayer K, Field S, Nakajima M, Broom EL, Hobbs NZ, Huxford B, Donkor N, Camboe E, Dey KC, Zirra A, Ahmed A, Gameiro Costa AR, …Parkinson's Disease · London Read Article

Cause and Affect…It’s not what you know but what you do.

Being more education has been considered to protect you from the ravages of MS, but is this true. In this Swedish Study they looked at the education level i.e. when you left teaching and whilst the…Education · Sweden Read Article

The Tyruko-Tysabri SH1-Show Part I. PML tests

This week we have been looking at the SH1 show created by the makers of Natalizumab. Tysabri was the original and as its patents ran out Tyruko was made and NICE said “use it”. However …Tweet · Italy Read Article

Early treatment with Natalizumab.

Tweet European Association of Neurology Meeting Sirito T et al. EPO-288 | Optimizing rapid inflammation controland risk management in highly active multiple sclerosis:The role of natalizumabBackground and aims: The rapid initiation of disease modifying therapies (DMTs) in patients with Highly Active Multiple Sclerosis (HAMS) facilitates prompt suppression of inflammatory activity. However, this approach requires a careful balance between efficac…London, England · London Read Article

Guessing why natalizumab doesn’t work for everybody.

This morning I presented some work to the clinical team about natalizumab and showed them that it doesn’t work for everybody. I also showed them a way to keep an eye on this and so it is of i…Tweet Read Article

Microbiome Differential Abundance Methods Produce Different Results Across 38 Datasets

100% Center coverage: 1 sources

Identifying differentially abundant microbes is a common goal of microbiome studies. Multiple methods are used interchangeably for this purpose in the literature. Yet, there are few large-scale studies systematically exploring the appropriateness of using these tools interchangeably, and the scale and significance of the differences between them. Here, we compare the performance of 14 differential abundance testing methods on 38 16S rRNA gene da…See the Story

Shitomics gives us some Bacteria to Cause MS

Open the article to view the coverage from Multiple Sclerosis Research BlogMultiple Sclerosis Read Article

MS is a length dependent axonopathy

A few years ago in response to some people (sadly opinion leaders) saying it was too late to treat some people with current drugs, we wrote about the length dependent axonopathy. So whilst it may l…United Kingdom · United Kingdom Read Article

Breaking News Topics Related to Multiple Sclerosis Research Blog